Direct anticancer activity of gonadotropin-releasing hormone-III

Journal of Peptide Research

Volumn 52, Issue 5, 1998, Pages 384-389

  Lovas, Sándor ^a   Palyi I ^b   Vincze, B ^b   Horvath J ^c   Kovacs M ^c   Mezo I ^d   Toth G ^e   Teplan I ^d   Murphy, R F ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^e INSTITUTE OF BIOCHEMISTRY   (Hungary)

Author keywords

Anticancer activity; Endocrine activity; GnRH; GnRH III

Indexed keywords

ESTROGEN RECEPTOR; GONADORELIN; GONADORELIN AGONIST; GONADORELIN RECEPTOR; LUTEINIZING HORMONE; OVURELIN; TESTOSTERONE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; BREAST CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOPHYSIS CELL; LIGAND BINDING; LUTEINIZING HORMONE RELEASE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RADIOIMMUNOASSAY; RAT; RECEPTOR BINDING;

ANIMALIA; MAMMALIA; PETROMYZON MARINUS; PETROMYZONTIDAE; SEA LAMPREYS;

EID: 0344141211     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3011.1998.tb00662.x     Document Type: Article

References (15)

1. Sharoni, Y., Bosin, E., Miinster, A., Levy, L. & Schally, A.V. (1989) Proc. Natl. Acad. Sci. USA 86, 1648-1651
2. Eidene, K.A., Flanagan, C.A. & Millar, R.P. (1985) Science 229, 989-991
3. Fekete, M., Bajusz, S., Groot, K., Csernus, V.J. & Schally, A.V. (1989) Endocrinology 124, 946-955
4. Segal-Abramson, T., Kitroser, H., Levy, J. & Schally, A.V. (1991) Proc. Natl. Acad. Sci. USA 89, 2336-2339
5. Vincze, B., Pályi, I., Daubner, D., Kremmer, T., Számel, I., Bodrogi, I., Sugar, J., Seprödi, J., Mezö, I. & Teplán I. (1991) J. Steroid Biochem. Mol. Biol. 38, 119-126
6. Scott, W.N., Muller, P. & Miller, W.R. (1991) Eur. J. Cancer 27, 1458-1461
7. Sower, S.A., Chiang, Y.-C., Lovas, S. & Conlon, J.M. (1993) Endocrinology 132, 1125-1131
8. Rivier, J., Rivier, C., Perrin, M., Porter, J. & Vale, W.W. (1981) in LHRH Peptides as Female and Male Contraceptives (Zatuchni, G.I., Shelton, J.D. & Sciarra, J.J., eds.), pp. 13-23, Harper and Row, Philadelphia, PA
9. Nikiforovich, G.V. & Marshall, G.R. (1993) Int. J. Peptide Protein Res. 42, 171-180
10. Deragon, K.L. & Sower, S.A. (1994) General and Comp. Endocrinol. 95, 363-367
11. Horváth J.E., Kéri Gy., Seprödi A., Teplán I. & Flerkó B. (1992) J. Neuroendocrinol. 4, 565-573
12. Mezö, I., Lovas, S., Pályi, I., Vincze, B., Kálnay, A., Turi, G., Vadász, Zs., Seprödi, J., Tóth, G., Gulyás, E., Ötvös, F., Mák, M., Horváth, J.E., Teplán, I. & Murphy, R.F. (1997) J. Med. Chem. 40, 3353-3358
13. Kovács, M., Mezö, I., Seprödi, J., Csernus, V., Teplán, I. & Flerkó, B. (1989) Peptides 10, 925-931
14. Vincze, B., Pályi, I., Daubner, D., Kàlnay, A., Mezö, G., Hudecz, F., Szekerke, M., Teplán, I. & Mezö, I. (1994) J. Cancer Res. Clin Oncol. 120, 578-584
15. Pinski, J., Schally, A.V., Yano, T., Groot, K., Srkalovic, G., Serfozo, P., Reissmann, T., Bernd, M., Deger, W., Kutscher, B. & Engel, J. (1995) Int. J. Peptide Protein Res. 45, 410-417